Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma

NCT06117878 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteosarcoma
Soft Tissue Sarcoma

Interventions

DRUG: NK510
DRUG: NK510

Sponsor

Base Therapeutics (Shanghai) Co., Ltd.

Collaborators

[object Object]